<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04742244</url>
  </required_header>
  <id_info>
    <org_study_id>00002</org_study_id>
    <nct_id>NCT04742244</nct_id>
  </id_info>
  <brief_title>Lemon Verbena Extract Oxidative Stress and Muscle Damage</brief_title>
  <official_title>Evaluation of the Efficacy of Supplementation With Lemon Verbena Extract in Improving</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan Sport University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan Sport University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present study, investigators investigated whether supplementation with lemon verbena&#xD;
      extract (LVE) could improve muscle damage and biochemical indicators after exhaustive&#xD;
      exercise challenge. Based on maximum jump heights, 60 subjects (30 males and 30 females) were&#xD;
      equally divided into a placebo group (0 mg/human/day) and an LVE supplement group (400&#xD;
      mg/human/day), with gender-equal distribution. All subjects started supplementation 10 days&#xD;
      before exhaustive exercise and continued it until all tests were completed. Before the&#xD;
      intervention, after the exhaustive exercise, and on the following 3 days, the participants&#xD;
      underwent 12-minute Cooper running/walking; blood collection; assessments of pain, muscle&#xD;
      stiffness, maximum jump heights, and isometric maximum muscle strength; and anaerobic&#xD;
      strength tests.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 28, 2020</start_date>
  <completion_date type="Actual">August 13, 2020</completion_date>
  <primary_completion_date type="Actual">July 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>inflammation of IL-6 level</measure>
    <time_frame>10 days</time_frame>
    <description>To assess inflammation indicators, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, including baseline (0) and 3h, 24h, and 48 after exercise, blood samples were collected with brachial venous catheters. Assess serum IL-6 levels (pg/ml) to monitor physiological fitness. Used commercial kit human IL-6 immunoassay (R&amp;D system, Minnesota, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Biochemistry of CK level</measure>
    <time_frame>10 days</time_frame>
    <description>To assess muscle damage, volunteers fasted for at least 8 hours before performing muscle exhaustion exercises. At designated time points in the recovery period, including baseline (0) and 3h, 24h, and 48 after exercise, blood samples were collected with brachial venous catheters. Serum CK (U/L), were assessed for monitoring physiological adaptation. All biochemical indices were assessed using an autoanalyzer (Hitachi 7060, Tokyo, Japan).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Stress hormones 8-Hydroxy-2'-Deoxyguanosine (8-OHdG) in Urine</measure>
    <time_frame>10 days</time_frame>
    <description>Subjects' urine was collected 24 hours after the exhaustive exercise for analysis. Used commercial kit human 8-OHdG (Cayman, Mich, USA) and Elisa reader (PerkinElmer, Massachusetts, USA) for analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of muscle stiffness</measure>
    <time_frame>10 days</time_frame>
    <description>3 h, 24h, 48h after exhausting exercise, use Myoton machine to evaluate muscle stiffness (N/m) (Myoton, Tallinn, Estonia)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale (VAS) evaluation</measure>
    <time_frame>10 days</time_frame>
    <description>3 h, 24h, 48h after exhausting exercise, use VAS questionnaire to record muscle pain. the minimum is 0 and maximum is 10, and whether higher scores mean more pain</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Muscle Injury</condition>
  <condition>Muscle Soreness</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0 mg LVE/capsule, 2capsule/day, 14days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lemon Verbena extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200 mg LVE/capsule, 2capsule/day, 14days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lvemon verbena extract</intervention_name>
    <description>Each capsule contained 200 mg of lemon verbena extract 2 capsules/day, 14 days</description>
    <arm_group_label>Lemon Verbena extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>maltodextrin</intervention_name>
    <description>Each capsule contained 0 mg of lemon verbena extract 2 capsules/day, 14 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  health&#xD;
&#xD;
          -  Must be able to swallow tablets&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  non-smokers&#xD;
&#xD;
          -  no musculoskeletal&#xD;
&#xD;
          -  medical&#xD;
&#xD;
          -  metabolic disease&#xD;
&#xD;
          -  women not on the reproductive cycle&#xD;
&#xD;
          -  high blood pressure, asthma&#xD;
&#xD;
          -  skeletal neuromuscular injuries in the upper or lower extremities&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chi-Chang Huang, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>PI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan Sport University</name>
      <address>
        <city>Taoyuan</city>
        <zip>333</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 25, 2021</study_first_submitted>
  <study_first_submitted_qc>February 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2021</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Taiwan Sport University</investigator_affiliation>
    <investigator_full_name>Chi-Chang Huang</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>DOMS,</keyword>
  <keyword>Lemon verbena</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myalgia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

